Operating profit before deduction of amortization: Eledon Pharmaceuticals, Inc. (ELDN)
Eledon Pharmaceuticals (ELDN) optimizes molecule trials through external contractors while maintaining full control over patents. The base EBITDA reflects daily earnings dynamics, with the metric currently standing at 0.00. Long-term contracts for treating autoimmune pathologies drive profit growth, while drug synthesis efficiency is enhanced through the implementation of robotic molecular design.
Eledon Pharmaceuticals, Inc. (ELDN) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
Debt to Equity Ratio Eledon Pharmaceuticals|ELDN - Long-Term Debt to Capital|Current Liabilities to Capital Eledon Pharmaceuticals Inc.|ELDN - Company Aggregate Debts|Debts to Book Value Eledon Pharmaceuticals|ELDN - Company Long-Term Debt|Company Short-Term Debt Eledon Pharmaceuticals|Immediate Liquidity eledon.com
- earnings and multiples data:
ELDN - Net Profit|Net Profit Forecast Eledon Pharmaceuticals|ELDN - Price to Earnings Ratio|Projected Price to Earnings Ratio eledon.com|ELDN - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Eledon Pharmaceuticals|ELDN - Operating profit before deduction of amortization|Earnings per share for the trailing year Eledon Pharmaceuticals|ELDN - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months eledon.com|ELDN - Earnings growth in current year|Expected earnings per share trend next year Eledon Pharmaceuticals
Summary company analytics:Eledon Pharmaceuticals
This indicator is calculated as the daily cash flow from operating activities excluding depreciation and tax effects, allowing for an assessment of the business's real operational efficiency. The stability of the EBITDA metric confirms the resilience of Eledon Pharmaceuticals (ELDN) within an independent product cycle, transforming biotechnological developments into a reliable defensive asset that remains independent of the global macroeconomic environment.
Competitors of Eledon Pharmaceuticals (ELDN)
Operating income before deduction of amortization argenx BVBA (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax S.A. (ABVX) - Operating profit before deduction of amortization|ADMA Biologics, Inc. (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Protagonist Therapeutics, Inc.|Operating profit before deduction of amortization IMVT|Operating profit EBITDA Kiniksa Corp|Profit before payment of interest, taxes and amortization Grifols, S.A. (GRFS)|adaptivebiotech.com - Operating profit before amortization|Operating profit EBITDA CLDX (Celldex Therapeutics, Inc.)|Aurinia Pharmaceuticals Inc (AUPH) - Profit before interest, taxes and amortization|BioCryst Pharmaceuticals Inc - Operating profit EBITDA|Profit before interest, taxes and amortization Vera Corp|Dianthus Therapeutics (DNTH) - Profit before payment of interest, taxes and amortization|PHVS (pharvaris.com) - Profit before payment of interest, taxes and amortization|ABCL (AbCellera Biologics Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization Tourmaline Bio Inc TRML|Operating profit EBITDA PGEN|Pharming Corp - Operating profit before amortization|Profit before payment of interest, taxes and amortization Nektar Therapeutics NKTR|upstreambio.com (UPB) - Profit before interest, taxes and amortization|ZBIO - Profit before payment of interest, taxes and amortization|IMNM (Immunome Inc) - Operating profit before amortization|GOSS (Gossamer Corp) - Operating profit before deduction of amortization|KalVista Corp - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Septerna Inc|pieris.com - Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA SVRA|RIGL (Rigel Pharma) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA ANAB (AnaptysBio Corp)|Operating profit EBITDA Astria Corp ATXS|ENGN - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization RAPT (RAPT Therapeutics Inc.)|aerovatetx.com (JBIO) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Aclaris Therapeutics Inc.|KYTX (Kyverna) - Operating profit EBITDA|Operating profit EBITDA Tiziana Life Sciences, Ltd.|Operating profit EBITDA CABA|Operating profit before deduction of amortization ventyxbio.com VTYX|Operating profit EBITDA THTX (Theratechnologies)|Avalo Therapeutics, Inc. (AVTX) - Profit before interest, taxes and amortization|AGEN: Operating profit before deduction of amortization|CLYM - Operating profit EBITDA|ZURA (Zura Bio) - Operating profit before deduction of amortization|ATYR: Company profit before taxes, interest and amortization|ADAG (Adagene Inc) - Operating profit EBITDA|Ikena Oncology, Inc. (IMA) - Operating income before deduction of amortization|Operating profit EBITDA STTK|Operating profit before deduction of amortization equilliumbio.com EQ|Operating profit EBITDA CNTB (Connect Biopharma Holdings Limited)|Operating profit EBITDA Immunic Therapeutics IMUX|ATRA - Profit before payment of interest, taxes and amortization|IFRX: Profit before payment of interest, taxes and amortization|X4 Pharma (XFOR) - Profit before payment of interest, taxes and amortization|ACET - Operating income before deduction of amortization|CELU (Celularity Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization inmunebio.com INMB|Profit before payment of interest, taxes and amortization Barinthus Biotherapeutics plc (BRNS)|Profit before payment of interest, taxes and amortization KZR (Kezar Life Sciences Inc.)|Operating profit EBITDA SABS (SAB Biotherapeutics, Inc)|AKTX: Operating profit before amortization|ENLV - Profit before payment of interest, taxes and amortization|QTTB (Q32 Bio Inc.) - Operating profit before amortization|GeoVax (GOVX) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization EDSA (Edesa Biotech Inc)|IBIO (iBio Corp) - Operating profit EBITDA|CARM: Income before deduction of interest, taxes and amortization|Operating profit EBITDA XTLB|Operating profit EBITDA boltbio.com (BOLT)|Profit before payment of interest, taxes and amortization HCW Biologics HCWB|Income before deduction of interest, taxes and amortization APVO|AIM - Profit before payment of interest, taxes and amortization|Aditxt (ADTX) - Operating profit before deduction of amortization|GRI: Operating profit EBITDA|xortx.com (XRTX) - Operating profit EBITDA|Operating profit before deduction of amortization HIND|REVB: Income before deduction of interest, taxes and amortization|Operating profit EBITDA INDP|Operating income before deduction of amortization BiondVax Pharmaceuticals|Profit before payment of interest, taxes and amortization CalciMedica CALI|AFMD - Operating profit before deduction of amortization|ALLK - Profit before payment of interest, taxes and amortization|HOOKIPA Pharma Inc. (HOOK) - Operating profit before deduction of amortization|IGMS (igmbio.com) - Operating profit before deduction of amortization|iTeos Pharma (ITOS) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Ocean Biomedical, Inc.|Operating profit before amortization TCBP (tcbiopharm.com)|Operating profit EBITDA THRD
